Annual report pursuant to Section 13 and 15(d)

Derivative Liabilities (Tables)

v3.21.2
Derivative Liabilities (Tables)
12 Months Ended
Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of changes in the fair value of Level 3 derivative liabilities that are measured at fair value on a recurring basis
    For the Year Ended December 31, 2020  
    Warrants     Convertible Notes     Preferred Stock     Total  
Beginning balance as of January 1, 2020   $ -     $ -     $ -     $ -  
Derivative liabilities assumed at date of Business Combination     2,754,865       23,500       1,167,000       3,945,365  
Derecognition of derivative liabilities in connection with convertible note and preferred stock modifications and exchanges     -       (723,336 )     (2,033,068 )     (2,756,404 )
Issuance of derivative liabilities             1,219,700       218,000       1,437,700  
Change in fair value of derivative liabilities     1,462,305       (294,064 )     648,068       1,816,309  
Ending balance as of December 31, 2020   $ 4,217,170     $ 225,800     $ -     $ 4,442,970  
Schedule of option pricing models to derivatives assumed
    November 6,
2020
 
Riske free interest rate   0.08% - 0.40%
Expected term (years)   0.26 - 5.01  
Expected volatility   80% - 207%
Expected dividends   0.00%
    November 25,
2020
 
Riske free interest rate   0.06% - 0.09%  
Expected term (years)   0.24 - 0.54  
Expected volatility   115% - 160%  
Expected dividends   0.00%
    For the Year Ended  
    December 31,
2020
 
Riske free interest rate   0.03% - 0.09%  
Expected term (years)   0.15 - 0.50  
Expected volatility   105% - 150%  
Expected dividends   0.00%
    December 31,
2020
 
Riske free interest rate   0.00% - 0.36%  
Expected term (years)   0.11 - 4.85  
Expected volatility   84% - 207%  
Expected dividends   0.00%
Schedule of warrant activity
                  Weighted        
            Weighted     Average        
            Average     Remaining     Aggregate  
      Number of     Exercise     Life     Intrinsic  
      Warrants     Price     In Years     Value  
Outstanding, January 1, 2020       -     $ -                  
Issued       6,064,908       11.43                  
Outstanding, December 31, 2020       6,064,908     $ 11.43       4.9     $       -  
                                   
Exercisable, December 31, 2020       6,001,250     $ 11.50       4.9     $ -  
Schedule of information related to stock warrants
Warrants Outstanding     Warrants Exercisable  
      Outstanding     Weighted Average     Exercisable  
Exercise     Number of     Remaining Life     Number of  
Price     Warrants     In Years     Warrants  
$ 11.50       6,001,250       4.9       6,001,250  
$ 5.28       63,658       -       -  
          6,064,908       4.9       6,001,250